Beta blockers for CHF

Adrenergic blockade dramatically reduces morbidity and mortality

Ravi K. Garg Dr Garg is a fellow in cardiology and Dr Sorrentino is associate professor of medicine, department of medicine, section of cardiology, University of Chicago Pritzker School of Medicine, Chicago.

, MD &

Matthew J. Sorrentino Dr Garg is a fellow in cardiology and Dr Sorrentino is associate professor of medicine, department of medicine, section of cardiology, University of Chicago Pritzker School of Medicine, Chicago.Correspondence[email protected]

, MD

PREVIEW

Congestive heart failure (CHF) afflicts more than 4 million people in the United States, and about 500,000 new cases are diagnosed each year. Heart failure is one of the most common reasons for hospitalization in this country, and morbidity and mortality rates are high. However, as this article points out, the prognosis in patients with CHF can be significantly improved by appropriate drug therapy. Drs Garg and Sorrentino review evidence supporting the use of beta blockers in CHF and provide practical information about when and how to use these drugs.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Beta blockers for CHF

Adrenergic blockade dramatically reduces morbidity and mortality

Information for

Open access

Opportunities

Help and information

Beta blockers for CHF

Adrenergic blockade dramatically reduces morbidity and mortality

PREVIEW

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date

Your download is now in progress and you may close this window

Login or register to access this feature